Searcharxiv⌕ Search

arXiv subjects

Lu Tian

Publications and source records attributed to Lu Tian.

At least 55 records · Page 3Linked to original sources

Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective

Developing drugs for rare diseases presents unique challenges from a statistical perspective. These challenges may include slowly progressive diseases with unmet medical needs, poorly understood natural history, small population size, diversified phenotypes and geneotypes within a disorder, and lack of appropriate surrogate endpoints to measure clinical benefits. The Real-World Evidence (RWE) Scientific Working Group of the American Statistical Association Biopharmaceutical Section has assembled a research team to assess the landscape including challenges and possible strategies to address these challenges and the role of real-world data (RWD) and RWE in rare disease drug development. This paper first reviews the current regulations by regulatory agencies worldwide and then discusses in more details the challenges from a statistical perspective in the design, conduct, and analysis of rare disease clinical trials. After outlining an overall development pathway for rare disease drugs, corresponding strategies to address the aforementioned challenges are presented. Other considerations are also discussed for generating relevant evidence for regulatory decision-making on drugs for rare diseases. The accompanying paper discusses how RWD and RWE can be used to improve the efficiency of rare disease drug development.

stat.AP↗

Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective

Real-world data (RWD) and real-world evidence (RWE) have been increasingly used in medical product development and regulatory decision-making, especially for rare diseases. After outlining the challenges and possible strategies to address the challenges in rare disease drug development (see the accompanying paper), the Real-World Evidence (RWE) Scientific Working Group of the American Statistical Association Biopharmaceutical Section reviews the roles of RWD and RWE in clinical trials for drugs treating rare diseases. This paper summarizes relevant guidance documents and frameworks by selected regulatory agencies and the current practice on the use of RWD and RWE in natural history studies and the design, conduct, and analysis of rare disease clinical trials. A targeted learning roadmap for rare disease trials is described, followed by case studies on the use of RWD and RWE to support a natural history study and marketing applications in various settings.

stat.AP↗

Diagram Formalization Enhanced Multi-Modal Geometry Problem Solver

Mathematical reasoning remains an ongoing challenge for AI models, especially for geometry problems that require both linguistic and visual signals. As the vision encoders of most MLLMs are trained on natural scenes, they often struggle to understand geometric diagrams, performing no better in geometry problem solving than LLMs that only process text. This limitation is amplified by the lack of effective methods for representing geometric relationships. To address these issues, we introduce the Diagram Formalization Enhanced Geometry Problem Solver (DFE-GPS), a new framework that integrates visual features, geometric formal language, and natural language representations. We propose a novel synthetic data approach and create a large-scale geometric dataset, SynthGeo228K, annotated with both formal and natural language captions, designed to enhance the vision encoder for a better understanding of geometric structures. Our framework improves MLLMs' ability to process geometric diagrams and extends their application to open-ended tasks on the formalgeo7k dataset.

cs.CV↗

Enhancing One-shot Pruned Pre-trained Language Models through Sparse-Dense-Sparse Mechanism

Pre-trained language models (PLMs) are engineered to be robust in contextual understanding and exhibit outstanding performance in various natural language processing tasks. However, their considerable size incurs significant computational and storage costs. Modern pruning strategies employ one-shot techniques to compress PLMs without the need for retraining on task-specific or otherwise general data; however, these approaches often lead to an indispensable reduction in performance. In this paper, we propose SDS, a Sparse-Dense-Sparse pruning framework to enhance the performance of the pruned PLMs from a weight distribution optimization perspective. We outline the pruning process in three steps. Initially, we prune less critical connections in the model using conventional one-shot pruning methods. Next, we reconstruct a dense model featuring a pruning-friendly weight distribution by reactivating pruned connections with sparse regularization. Finally, we perform a second pruning round, yielding a superior pruned model compared to the initial pruning. Experimental results demonstrate that SDS outperforms the state-of-the-art pruning techniques SparseGPT and Wanda under an identical sparsity configuration. For instance, SDS reduces perplexity by 9.13 on Raw-Wikitext2 and improves accuracy by an average of 2.05% across multiple zero-shot benchmarks for OPT-125M with 2:4 sparsity.

cs.CL↗

Towards Scale-Aware Full Surround Monodepth with Transformers

Full surround monodepth (FSM) methods can learn from multiple camera views simultaneously in a self-supervised manner to predict the scale-aware depth, which is more practical for real-world applications in contrast to scale-ambiguous depth from a standalone monocular camera. In this work, we focus on enhancing the scale-awareness of FSM methods for depth estimation. To this end, we propose to improve FSM from two perspectives: depth network structure optimization and training pipeline optimization. First, we construct a transformer-based depth network with neighbor-enhanced cross-view attention (NCA). The cross-attention modules can better aggregate the cross-view context in both global and neighboring views. Second, we formulate a transformer-based feature matching scheme with progressive training to improve the structure-from-motion (SfM) pipeline. That allows us to learn scale-awareness with sufficient matches and further facilitate network convergence by removing mismatches based on SfM loss. Experiments demonstrate that the resulting Scale-aware full surround monodepth (SA-FSM) method largely improves the scale-aware depth predictions without median-scaling at the test time, and performs favorably against the state-of-the-art FSM methods, e.g., surpassing SurroundDepth by 3.8% in terms of accuracy at delta<1.25 on the DDAD benchmark.

cs.CV↗

VIPS-Odom: Visual-Inertial Odometry Tightly-coupled with Parking Slots for Autonomous Parking

Precise localization is of great importance for autonomous parking task since it provides service for the downstream planning and control modules, which significantly affects the system performance. For parking scenarios, dynamic lighting, sparse textures, and the instability of global positioning system (GPS) signals pose challenges for most traditional localization methods. To address these difficulties, we propose VIPS-Odom, a novel semantic visual-inertial odometry framework for underground autonomous parking, which adopts tightly-coupled optimization to fuse measurements from multi-modal sensors and solves odometry. Our VIPS-Odom integrates parking slots detected from the synthesized bird-eye-view (BEV) image with traditional feature points in the frontend, and conducts tightly-coupled optimization with joint constraints introduced by measurements from the inertial measurement unit, wheel speed sensor and parking slots in the backend. We develop a multi-object tracking framework to robustly track parking slots' states. To prove the superiority of our method, we equip an electronic vehicle with related sensors and build an experimental platform based on ROS2 system. Extensive experiments demonstrate the efficacy and advantages of our method compared with other baselines for parking scenarios.

cs.RO↗

The Ninth NTIRE 2024 Efficient Super-Resolution Challenge Report

This paper provides a comprehensive review of the NTIRE 2024 challenge, focusing on efficient single-image super-resolution (ESR) solutions and their outcomes. The task of this challenge is to super-resolve an input image with a magnification factor of x4 based on pairs of low and corresponding high-resolution images. The primary objective is to develop networks that optimize various aspects such as runtime, parameters, and FLOPs, while still maintaining a peak signal-to-noise ratio (PSNR) of approximately 26.90 dB on the DIV2K_LSDIR_valid dataset and 26.99 dB on the DIV2K_LSDIR_test dataset. In addition, this challenge has 4 tracks including the main track (overall performance), sub-track 1 (runtime), sub-track 2 (FLOPs), and sub-track 3 (parameters). In the main track, all three metrics (ie runtime, FLOPs, and parameter count) were considered. The ranking of the main track is calculated based on a weighted sum-up of the scores of all other sub-tracks. In sub-track 1, the practical runtime performance of the submissions was evaluated, and the corresponding score was used to determine the ranking. In sub-track 2, the number of FLOPs was considered. The score calculated based on the corresponding FLOPs was used to determine the ranking. In sub-track 3, the number of parameters was considered. The score calculated based on the corresponding parameters was used to determine the ranking. RLFN is set as the baseline for efficiency measurement. The challenge had 262 registered participants, and 34 teams made valid submissions. They gauge the state-of-the-art in efficient single-image super-resolution. To facilitate the reproducibility of the challenge and enable other researchers to build upon these findings, the code and the pre-trained model of validated solutions are made publicly available at https://github.com/Amazingren/NTIRE2024_ESR/.

cs.CV↗

Exact Inference for Random Effects Meta-Analyses with Small, Sparse Data

Meta-analysis aggregates information across related studies to provide more reliable statistical inference and has been a vital tool for assessing the safety and efficacy of many high profile pharmaceutical products. A key challenge in conducting a meta-analysis is that the number of related studies is typically small. Applying classical methods that are asymptotic in the number of studies can compromise the validity of inference, particularly when heterogeneity across studies is present. Moreover, serious adverse events are often rare and can result in one or more studies with no events in at least one study arm. Practitioners often apply arbitrary continuity corrections or remove zero-event studies to stabilize or define effect estimates in such settings, which can further invalidate subsequent inference. To address these significant practical issues, we introduce an exact inference method for comparing event rates in two treatment arms under a random effects framework, which we coin "XRRmeta". In contrast to existing methods, the coverage of the confidence interval from XRRmeta is guaranteed to be at or above the nominal level (up to Monte Carlo error) when the event rates, number of studies, and/or the within-study sample sizes are small. Extensive numerical studies indicate that XRRmeta does not yield overly conservative inference and we apply our proposed method to two real-data examples using our open source R package.

stat.ME↗

LADDER: An Efficient Framework for Video Frame Interpolation

Video Frame Interpolation (VFI) is a crucial technique in various applications such as slow-motion generation, frame rate conversion, video frame restoration etc. This paper introduces an efficient video frame interpolation framework that aims to strike a favorable balance between efficiency and quality. Our framework follows a general paradigm consisting of a flow estimator and a refinement module, while incorporating carefully designed components. First of all, we adopt depth-wise convolution with large kernels in the flow estimator that simultaneously reduces the parameters and enhances the receptive field for encoding rich context and handling complex motion. Secondly, diverging from a common design for the refinement module with a UNet-structure (encoder-decoder structure), which we find redundant, our decoder-only refinement module directly enhances the result from coarse to fine features, offering a more efficient process. In addition, to address the challenge of handling high-definition frames, we also introduce an innovative HD-aware augmentation strategy during training, leading to consistent enhancement on HD images. Extensive experiments are conducted on diverse datasets, Vimeo90K, UCF101, Xiph and SNU-FILM. The results demonstrate that our approach achieves state-of-the-art performance with clear improvement while requiring much less FLOPs and parameters, reaching to a better spot for balancing efficiency and quality.

cs.CV↗

Sparse Laneformer

Lane detection is a fundamental task in autonomous driving, and has achieved great progress as deep learning emerges. Previous anchor-based methods often design dense anchors, which highly depend on the training dataset and remain fixed during inference. We analyze that dense anchors are not necessary for lane detection, and propose a transformer-based lane detection framework based on a sparse anchor mechanism. To this end, we generate sparse anchors with position-aware lane queries and angle queries instead of traditional explicit anchors. We adopt Horizontal Perceptual Attention (HPA) to aggregate the lane features along the horizontal direction, and adopt Lane-Angle Cross Attention (LACA) to perform interactions between lane queries and angle queries. We also propose Lane Perceptual Attention (LPA) based on deformable cross attention to further refine the lane predictions. Our method, named Sparse Laneformer, is easy-to-implement and end-to-end trainable. Extensive experiments demonstrate that Sparse Laneformer performs favorably against the state-of-the-art methods, e.g., surpassing Laneformer by 3.0% F1 score and O2SFormer by 0.7% F1 score with fewer MACs on CULane with the same ResNet-34 backbone.

cs.CV↗

A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time-to-Event Outcomes Using Average Hazard with Survival Weight

Given the limitations of using the Cox hazard ratio to summarize the magnitude of the treatment effect, alternative measures that do not have these limitations are gaining attention. One of the recently proposed alternative methods uses the average hazard with survival weight (AH). This population quantity can be interpreted as the average intensity of the event occurrence in a given time window that does not involve study-specific censoring. Inference procedures for the ratio of AH and difference in AH have already been proposed in simple randomized controlled trial settings to compare two groups. However, methods with stratification factors have not been well discussed, although stratified analysis is often used in practice to adjust for confounding factors and increase the power to detect a between-group difference. The conventional stratified analysis or meta-analysis approach, which integrates stratum-specific treatment effects using an optimal weight, directly applies to the ratio of AH and difference in AH. However, this conventional approach has significant limitations similar to the Cochran-Mantel-Haenszel method for a binary outcome and the stratified Cox procedure for a time-to-event outcome. To address this, we propose a new stratified analysis method for AH using standardization. With the proposed method, one can summarize the between-group treatment effect in both absolute difference and relative terms, adjusting for stratification factors. This can be a valuable alternative to the traditional stratified Cox procedure to estimate and report the magnitude of the treatment effect on time-to-event outcomes using hazard.

stat.ME↗

Assessing Delayed Treatment Benefits of Immunotherapy Using Long-Term Average Hazard: A Novel Test/Estimation Approach

Delayed treatment effects on time-to-event outcomes have often been observed in randomized controlled studies of cancer immunotherapies. In the case of delayed onset of treatment effect, the conventional test/estimation approach using the log-rank test for between-group comparison and Cox's hazard ratio to estimate the magnitude of treatment effect is not optimal, because the log-rank test is not the most powerful option, and the interpretation of the resulting hazard ratio is not obvious. Recently, alternative test/estimation approaches were proposed to address both the power issue and the interpretation problems of the conventional approach. One is a test/estimation approach based on long-term restricted mean survival time, and the other approach is based on average hazard with survival weight. This paper integrates these two ideas and proposes a novel test/estimation approach based on long-term average hazard (LT-AH) with survival weight. Numerical studies reveal specific scenarios where the proposed LT-AH method provides a higher power than the two alternative approaches. The proposed approach has test/estimation coherency and can provide robust estimates of the magnitude of treatment effect not dependent on study-specific censoring time distribution. Also, the proposed LT-AH approach can summarize the magnitude of the treatment effect in both absolute difference and relative terms using ``hazard'' (i.e., difference in LT-AH and ratio of LT-AH), meeting guideline recommendations and practical needs. This proposed approach can be a useful alternative to the traditional hazard-based test/estimation approach when delayed onset of survival benefit is expected.

stat.ME↗

UPDP: A Unified Progressive Depth Pruner for CNN and Vision Transformer

Traditional channel-wise pruning methods by reducing network channels struggle to effectively prune efficient CNN models with depth-wise convolutional layers and certain efficient modules, such as popular inverted residual blocks. Prior depth pruning methods by reducing network depths are not suitable for pruning some efficient models due to the existence of some normalization layers. Moreover, finetuning subnet by directly removing activation layers would corrupt the original model weights, hindering the pruned model from achieving high performance. To address these issues, we propose a novel depth pruning method for efficient models. Our approach proposes a novel block pruning strategy and progressive training method for the subnet. Additionally, we extend our pruning method to vision transformer models. Experimental results demonstrate that our method consistently outperforms existing depth pruning methods across various pruning configurations. We obtained three pruned ConvNeXtV1 models with our method applying on ConvNeXtV1, which surpass most SOTA efficient models with comparable inference performance. Our method also achieves state-of-the-art pruning performance on the vision transformer model.

cs.CV↗

Exact Inference for Common Odds Ratio in Meta-Analysis with Zero-Total-Event Studies

Stemming from the high profile publication of Nissen and Wolski (2007) and subsequent discussions with divergent views on how to handle observed zero-total-event studies, defined to be studies which observe zero events in both treatment and control arms, the research topic concerning the common odds ratio model with zero-total-event studies remains to be an unresolved problem in meta-analysis. In this article, we address this problem by proposing a novel repro samples method to handle zero-total-event studies and make inference for the parameter of common odds ratio. The development explicitly accounts for sampling scheme and does not rely on large sample approximation. It is theoretically justified with a guaranteed finite sample performance. The empirical performance of the proposed method is demonstrated through simulation studies. It shows that the proposed confidence set achieves the desired empirical coverage rate and also that the zero-total-event studies contains information and impacts the inference for the common odds ratio. The proposed method is applied to combine information in the Nissen and Wolski study.

stat.ME↗

Separated RoadTopoFormer

Understanding driving scenarios is crucial to realizing autonomous driving. Previous works such as map learning and BEV lane detection neglect the connection relationship between lane instances, and traffic elements detection tasks usually neglect the relationship with lane lines. To address these issues, the task is presented which includes 4 sub-tasks, the detection of traffic elements, the detection of lane centerlines, reasoning connection relationships among lanes, and reasoning assignment relationships between lanes and traffic elements. We present Separated RoadTopoFormer to tackle the issues, which is an end-to-end framework that detects lane centerline and traffic elements with reasoning relationships among them. We optimize each module separately to prevent interaction with each other and aggregate them together with few finetunes. For two detection heads, we adopted a DETR-like architecture to detect objects, and for the relationship head, we concat two instance features from front detectors and feed them to the classifier to obtain relationship probability. Our final submission achieves 0.445 OLS, which is competitive in both sub-task and combined scores.

cs.CV↗

Hierarchical Pretraining for Biomedical Term Embeddings

Electronic health records (EHR) contain narrative notes that provide extensive details on the medical condition and management of patients. Natural language processing (NLP) of clinical notes can use observed frequencies of clinical terms as predictive features for downstream applications such as clinical decision making and patient trajectory prediction. However, due to the vast number of highly similar and related clinical concepts, a more effective modeling strategy is to represent clinical terms as semantic embeddings via representation learning and use the low dimensional embeddings as feature vectors for predictive modeling. To achieve efficient representation, fine-tuning pretrained language models with biomedical knowledge graphs may generate better embeddings for biomedical terms than those from standard language models alone. These embeddings can effectively discriminate synonymous pairs of from those that are unrelated. However, they often fail to capture different degrees of similarity or relatedness for concepts that are hierarchical in nature. To overcome this limitation, we propose HiPrBERT, a novel biomedical term representation model trained on additionally complied data that contains hierarchical structures for various biomedical terms. We modify an existing contrastive loss function to extract information from these hierarchies. Our numerical experiments demonstrate that HiPrBERT effectively learns the pair-wise distance from hierarchical information, resulting in a substantially more informative embeddings for further biomedical applications

cs.CL↗

An Empirical Bayes Approach for Constructing the Confidence Intervals of Clonality and Entropy

This paper is motivated by the need to quantify human immune responses to environmental challenges. Specifically, the genome of the selected cell population from a blood sample is amplified by the well-known PCR process of successive heating and cooling, producing a large number of reads. They number roughly 30,000 to 300,000. Each read corresponds to a particular rearrangement of so-called V(D)J sequences. In the end, the observation consists of a set of numbers of reads corresponding to different V(D)J sequences. The underlying relative frequencies of distinct V(D)J sequences can be summarized by a probability vector, with the cardinality being the number of distinct V(D)J rearrangements present in the blood. Statistical question is to make inferences on a summary parameter of the probability vector based on a single multinomial-type observation of a large dimension. Popular summary of the diversity of a cell population includes clonality and entropy, or more generally, is a suitable function of the probability vector. A point estimator of the clonality based on multiple replicates from the same blood sample has been proposed previously. After obtaining a point estimator of a particular function, the remaining challenge is to construct a confidence interval of the parameter to appropriately reflect its uncertainty. In this paper, we have proposed to couple the empirical Bayes method with a resampling-based calibration procedure to construct a robust confidence interval for different population diversity parameters. The method has been illustrated via extensive numerical study and real data examples.

stat.ME↗

Using a Surrogate with Heterogeneous Utility to Test for a Treatment Effect

The primary benefit of identifying a valid surrogate marker is the ability to use it in a future trial to test for a treatment effect with shorter follow-up time or less cost. However, previous work has demonstrated potential heterogeneity in the utility of a surrogate marker. When such heterogeneity exists, existing methods that use the surrogate to test for a treatment effect while ignoring this heterogeneity may lead to inaccurate conclusions about the treatment effect, particularly when the patient population in the new study has a different mix of characteristics than the study used to evaluate the utility of the surrogate marker. In this paper, we develop a novel test for a treatment effect using surrogate marker information that accounts for heterogeneity in the utility of the surrogate. We compare our testing procedure to a test that uses primary outcome information (gold standard) and a test that uses surrogate marker information, but ignores heterogeneity. We demonstrate the validity of our approach and derive the asymptotic properties of our estimator and variance estimates. Simulation studies examine the finite sample properties of our testing procedure and demonstrate when our proposed approach can outperform the testing approach that ignores heterogeneity. We illustrate our methods using data from an AIDS clinical trial to test for a treatment effect using CD4 count as a surrogate marker for RNA.

stat.ME↗